Virtus ETF Advisers’s Prime Medicine PRME Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-23,618	Closed	-$69K	–	565
2024 Q4	$69K	Buy	23,618 +11,948	+102%	+$34.9K	0.03%	385
2024 Q3	$45.2K	Buy	11,670 +211	+2%	+$817	0.02%	443
2024 Q2	$58.9K	Buy	+11,459	New	+$58.9K	0.03%	440